SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TITAN PHARMACEUTICAL (TTP) -- Ignore unavailable to you. Want to Upgrade?


To: sim1 who wrote (143)10/5/2000 8:14:18 AM
From: NeuroInvestment  Read Replies (1) | Respond to of 362
 
Last October I asked Titan if the ProNeura technology was to be used in a Zomaril depot formulation, and they said it was not. Novartis is doing the depot development inhouse (I do not have any info as to the nature or origin of their technology). NeuroInvestment (www.neuroinvestment.com)